PiperSandler News & Analysis
8 articles
Market Mood
Piper Sandler Forecasts Oil Prices to Rise Amid Hormuz Closure
Piper Sandler predicts that the Strait of Hormuz will remain largely closed for months, leading to a potential rise in oil prices. Currently, WTI crude futures are trading around $94 per barrel, down from nearly $120 at the conflict's onset. The bank expressed little confidence that the commercial traffic through the Strait would return to even 50% of its pre-crisis levels soon. This situation could exacerbate shortages and impact global economies reliant on Middle Eastern oil and LNG exports, raising concerns about the overall market.
Read More
Arista Networks (ANET) Price Target Raised to $181 by Piper Sandler
Piper Sandler raised Arista Networks, Inc.'s (ANET) price target from $175 to $181 and maintained an Overweight rating. The firm's analysis indicates that despite a 35% increase in shares over the past month, investors have become cautious due to rising concerns over growth and de-commitments. However, Arista is expected to maintain solid growth through 2026, supported by its positioning in AI markets. Notably, ANET's 5-year return has outperformed the S&P 500 by 538%.
Read More
AnaptysBio (ANAB) Price Target Reduced to $93 Amid Spinoff Completion
AnaptysBio, Inc. (ANAB) has had its price target cut by Piper Sandler from $95 to $93 while maintaining an Overweight rating. This adjustment followed the completion of the First Tracks Biotherapeutics (TRAX) spinoff announced in April 2026, transitioning ANAB to operate as a royalty management company. Additionally, on April 24, the Delaware Chancery Court dismissed a breach of contract claim against AnaptysBio by Tesaro, affirming that the company did not repudiate its agreements with Tesaro regarding Jemperli. These developments could influence investor sentiment and market performance for ANAB.
Read More
Becton Dickinson (BDX) Price Target Trimmed to $159 by Piper Sandler
Piper Sandler has reduced the price target for Becton, Dickinson and Company (BDX) from $170 to $159 while maintaining a Neutral rating. This adjustment was made on April 17, 2026, to align with management's revenue growth guidance. Additionally, RBC Capital Markets lowered its price target for BDX to $175 from $195, citing stable fundamentals in the MedTech sector. Both firms note that current sentiment around BDX may create investment opportunities, but they expect the stock to remain range-bound due to a lack of clear catalysts.
Read More
Charles Schwab (SCHW) Price Target Cut Due to AI Concerns
Piper Sandler has lowered the price target for Charles Schwab (SCHW), citing concerns related to artificial intelligence. The adjusted target reflects the firm's outlook amid increased competition and the potential impact of AI on financial services. Analysts are monitoring these developments closely as they may influence investor sentiment and market performance. The stock's performance amid these changes could be pivotal for investor decisions in the coming quarters.
Read More
Nike (NKE) Shares Down 30% This Year, Still Not Cheap
Piper Sandler has stated that Nike (NKE) shares have experienced a 30% decline this year. Despite this drop, analysts suggest that the shares remain overpriced. The assessment indicates that even after the significant drawdown, the company's stock does not present a buying opportunity at current levels. This perspective may influence investor sentiment and market behavior around Nike shares moving forward.
Read More
Bank stock buybacks seen as catalyst amid pullback, says Piper Sandler
Piper Sandler notes that bank stock buybacks could serve as a catalyst in the current market pullback. The firm highlights that buybacks can enhance earnings per share and support stock prices, particularly when trading volumes are lower. As banks initiate repurchase programs, the impact on their share prices may be significant. This trend is relevant to investors considering the overall health and performance of the banking sector amid fluctuating conditions.
Read More
Bill Ackman's Strategy: Aiming for a Berkshire-Hathaway Style Investment Model
Billionaire investor Bill Ackman is aspiring to replicate the successful investment model of Berkshire Hathaway, as assessed by Piper Sandler. The investment firm notes that Ackman's strategy will hinge on effectively managing insurance risk while maximizing investment returns. This ambition is particularly significant as it highlights a trend among investors looking to leverage insurance funds for broader market growth. Success in this venture could reshape market dynamics and influence investor confidence in alternative investment strategies.
Read More